Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Shill

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Brain Pathology (Zurich, Switzerland)|February 29, 2012
Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathiesLih-Fen Lue, Douglas G Walker, Charles H Adler, et al.
Neurology|May 1, 2021
A Shortage of Neurologists - We Must Act Now: A Report From the AAN 2019 Transforming Leaders ProgramJennifer J Majersik, Aiesha Ahmed, I-Hweii A Chen, et al.
Plos One|May 7, 2014
Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathologyKasandra Burgos, Ivana Malenica, Raghu Metpally, et al.
Neurology|June 25, 2026
Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson DiseaseCharles H Adler, Chelva Janarthanam, Geidy E Serrano, et al.
Current Alzheimer Research|January 27, 2017
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled TrialBoris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Neuronal gene expression correlates of Parkinson's disease with dementiaChelsea Stamper, Andrew Siegel, Winnie S Liang, et al.
Biochemical and Biophysical Research Communications|September 3, 2009
Abnormal serum concentrations of proteins in Parkinson's diseaseIra L Goldknopf, Jennifer K Bryson, Irina Strelets, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisCécilia Tremblay, Gabriella Frosi, Sidra Aslam, et al.
Acta Neuropathologica|June 23, 2025
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participantsAndrea Mastrangelo, Serena Caldera, Sophie E Mastenbroek, et al.
Alzheimer Disease and Associated Disorders|February 23, 2023
Research Priorities of Individuals and Caregivers With Lewy Body Dementia: A Web-based SurveySamantha K Holden, Noheli Bedenfield, Angela S Taylor, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Brain Pathology (Zurich, Switzerland)|February 29, 2012
Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathiesLih-Fen Lue, Douglas G Walker, Charles H Adler, et al.
Neurology|May 1, 2021
A Shortage of Neurologists - We Must Act Now: A Report From the AAN 2019 Transforming Leaders ProgramJennifer J Majersik, Aiesha Ahmed, I-Hweii A Chen, et al.
Plos One|May 7, 2014
Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathologyKasandra Burgos, Ivana Malenica, Raghu Metpally, et al.
Neurology|June 25, 2026
Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson DiseaseCharles H Adler, Chelva Janarthanam, Geidy E Serrano, et al.
Current Alzheimer Research|January 27, 2017
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled TrialBoris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Neuronal gene expression correlates of Parkinson's disease with dementiaChelsea Stamper, Andrew Siegel, Winnie S Liang, et al.
Biochemical and Biophysical Research Communications|September 3, 2009
Abnormal serum concentrations of proteins in Parkinson's diseaseIra L Goldknopf, Jennifer K Bryson, Irina Strelets, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisCécilia Tremblay, Gabriella Frosi, Sidra Aslam, et al.
Acta Neuropathologica|June 23, 2025
Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participantsAndrea Mastrangelo, Serena Caldera, Sophie E Mastenbroek, et al.
Alzheimer Disease and Associated Disorders|February 23, 2023
Research Priorities of Individuals and Caregivers With Lewy Body Dementia: A Web-based SurveySamantha K Holden, Noheli Bedenfield, Angela S Taylor, et al.
Pageof 4